Advances in Chronic Hepatitis C Treatment And Liver Transplantation: An Update

ISSUE: JANUARY, 2011
VOLUME: 62:01

The Center for the Study of Hepatitis C (CSHC) at NewYork-Presbyterian/Weill Cornell Medical Center is engaged in diverse HCV investigations. One of us (Dr. Talal) has undertaken research on viral kinetics, presenting the first evaluation of pegIFN pharmacokinetics in patients coinfected with HCV and HIV, finding that, although pharmacokinetic parameters do not differentiate sustained virological responders from nonresponders, certain pharmaco - dynamic measurements do and might therefore serve as useful predictors of treatment outcome.

PDF Download: Advances in Chronic Hepatitis C Treatment And Liver Transplantation: An Update (Acrobat Reader is required)

Source